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The pattern recognition theory proposed by the late Charles Janeway, Jr. 20 years ago provided a conceptual
framework for our current understanding of the innate immune recognition and its role in the activation of
adaptive immunity. Discovery of several families of pattern recognition receptors and their roles in mamma-
lian immunity provided experimental support for the Janeway’s theory. In addition to pattern recognition,
there are other forms of innate immune sensing, which presumably work in specific combinations depending
on the pathogen class and the type of the immune response they elicit. Here, the development of the Jane-
way’s theory is discussed in the context of the advances made in field of innate immune recognition over the
past two decades.‘‘It is amateurs who have one big bright beautiful idea that
they can never abandon. Professionals know that they
have to produce theory after theory before they are likely
to hit the jackpot.’’ Francis Crick, What Mad Pursuit: A
Personal View of Scientific Discovery (1988)
This year marks the 20th anniversary of a publication (Janeway,
1989) that in many ways revolutionized our understanding of
the immune system. As part of the proceedings of the Cold
Spring Harbor Symposium on Immune Recognition, the paper
authored by the late Charles A. Janeway, Jr. was not a standard
peer-reviewed publication. In fact, Charlie used to refer to it as
‘‘the best paper I’ve never published.’’ According to the Francis
Crick’s quotation above, Charlie was definitely a ‘‘professional’’
who had many ideas and who hit more than one jackpot. The
pattern recognition theory was the biggest one. In addition to
suggesting a general principle of innate immune recognition, it
provided a conceptual framework for the integration of the two
types of immunity—innate and acquired. It also suggested
a new set of ideas that explained the initiation of the immune
responses, the mechanism of adjuvant effects, and the evolution
of different forms of immune recognition. Collectively, these
ideas provided guiding principles for our current understanding
of the functioning of the innate immune system and its connec-
tion with adaptive immunity.
Early Studies on the Initiation of Innate and Adaptive
Immunity
In the late 80s and early 90s, immunologists focused much of
their attention on the mechanisms of adaptive immune recogni-
tion, including the structure and function of the antigen recep-
tors, the mechanisms of MHC restriction, and lymphocyte devel-
opment and activation. However, little was known about the
requirements for the activation of adaptive immune responses.
Although the question of self-nonself discrimination has preoc-
cupied the minds of immunologists for decades, the solution
was thought to be largely provided by the pioneering works of
Lederberg, Burnet, and Medawar (Billingham et al., 1953;
Burnet, 1959; Lederberg, 1959). The central idea at the time
was that the removal or inactivation of autoreactive clones during
lymphocyte development allowed the remaining lymphocytes to766 Immunity 30, June 19, 2009 ª2009 Elsevier Inc.respond to any antigens they may encounter because these by
definition would be nonself. The concept was later modified by
the two-signal model of Bretscher and Cohn (Bretscher and
Cohn, 1970) and by the costimulatory model suggested by
Lafferty and Cunningham (Lafferty and Cunningham, 1975).
The first experimental evidence for the two-signal requirement
for T cell activation was later provided by Marc Jenkins and
Ronald Schwartz (Jenkins and Schwartz, 1987), although the
nature of the second signal remained unknown for a few more
years. Importantly, however, in an unrelated line of studies, An-
tonio Coutinho and Go¨ran Mo¨ller discovered the distinct roles
of antigen-specific and polyclonal signals in B cell activation
(Coutinho and Moller, 1974). The polyclonal (or mitogenic) signal
in their experiments was provided by lipopolysaccharide (LPS),
and thus their studies made one of the first critical connections
between antigen-specific receptor and nonclonal microbial
receptors in activation of B cell responses. Other studies estab-
lished adjuvant properties of LPS (Condie et al., 1955; Skidmore
et al., 1976). In the meantime, Ralph Steinman, working in Zanvil
Cohn’s group, discovered dendritic cells and characterized their
unique immunostimulatory activity (Steinman and Cohn, 1973,
1974). A critical connection between the initiation of T and B
cell responses was provided by the discovery of antigen-specific
T and B cell interactions by Antonio Lanzavecchia (Lanzavec-
chia, 1985). Together, these and many other pioneering discov-
eries, including analyses of the specificity of antibody responses
by Karl Landsteiner (Landsteiner, 1945), provided the essential
background for future analyses of how the adaptive immune
response is initiated.
In parallel, fundamental advances were being made in studies
of the innate host defense mechanisms. During the 1970s, anal-
yses of antimicrobial mechanisms of neutrophils and macro-
phages, particularly by Zanvil Cohn and his many pupils and
collaborators, including James Hirsch, Seymour Klebanoff, Carl
Nathan, Siamon Gordon, Ralph Steinman, Alan Aderem, Ira
Mellman, Bill Muller, Gilla Kaplan, and many others, had estab-
lished many basic principles of macrophage and neutrophil func-
tions, including phagocytic process, degranulation, secretory
function, arachidonic acid metabolism, and oxygen-dependent
and -independent bacteriocidal functions (reviewed in Steinman
and Moberg, 1994). Many of these functions were found to be
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Bacillus Calmette-Gue´rin (BCG), and zymosan. Thus, the idea of
microbial stimulation of innate effector functions was well appre-
ciated by that time. In addition, the discovery of antimicrobial
peptides by Hans Boman revealed a powerful microbicidal
system, which is now known to be used by most and perhaps
all organisms for antimicrobial defense. In the field of antiviral
immunity, the crucial advances were the discovery of type I inter-
feron (IFN) activity (Isaacs and Lindenmann, 1957; Isaacs et al.,
1957; Nagano and Kojima, 1958), cloning of the first type I IFN
gene (IFN-b) by Tadatsugu Taniguchi (Taniguchi et al., 1980),
and the isolation of the IFN-a gene by Shigekazu Nagata and
Charles Weismann (Nagata et al., 1980). Importantly, type I IFNs
were known to be inducible by poly IC, presumably because it
mimics viral dsRNA—another important target of innate immune
recognition. Finally, characterization of two mouse strains defi-
cient in LPS responsiveness, C3H/HeJ (Heppner and Weiss,
1965) and C57BL/10Cr (Coutinho et al., 1977), and demonstration
of their susceptibility to a bacterial infection (O’Brien et al., 1980)
demonstrated that LPS recognition plays a critical role in host
defense against at least some Gram-negative pathogens.
The two lines of study briefly outlined above were developing
largely independently of each other, as reflected in the way the
innate and adaptive immune systems were covered in textbooks.
The critical role of innate immune recognition in the control of
adaptive immunity was not well appreciated and a new concep-
tual framework was clearly needed to integrate innate and adap-
tive immune recognition to explain the fundamental properties of
mammalian immunity.
Janeway’s Hypothesis
Charles Janeway’s unique contribution was in developing a new
synthesis that placed many immunological phenomena in a clear
biological context. First, he proposed that the costimulatory
signal required for lymphocyte activation was inducible (on
antigen-presenting cells [APCs]). Whether and how the costimu-
latory signals are regulated was not well understood at the time,
although expression of interleukin-1 (IL-1) by macrophages was
found by Emil Unanue and colleagues to be one of them (Weaver
et al., 1988). Second, the costimulatory signal was suggested to
be inducible by conserved microbial products, thus placing the
activation of adaptive immunity under the control of pathogen-
sensing mechanisms. This also explained the adjuvant proper-
ties of certain microbial stimuli. The fact that many microbial
molecules, such as LPS, had immunostimulatory properties
was known before, but it was not clear why some microbial
molecules have these properties, including adjuvant activity,
whereas others do not. Neither was it known how these microbial
structures exerted their adjuvant effects. Janeway suggested
that the actual detection of infection was mediated by the recep-
tors of the innate immune system, rather than the antigen recep-
tors. Specifically, he proposed that innate immune system deter-
mined the origin of antigens recognized by T and B cells and
instructed the latter to initiate the response if antigen was of
microbial origin. Pathogen sensing, in turn, was proposed to
be mediated by a set of germline-encoded pattern recognition
receptors that detect conserved products of microbial biosyn-
thetic pathways (known as pathogen-associated molecular
patterns [PAMPs]). Janeway further pointed out that this formof immune recognition must be evolutionarily related to the
immune systems of invertebrates, which lack adaptive immunity.
Finally, most adjuvants were suggested to work in part by
mimicking microbial infections, by triggering the receptors of
the innate immune system and inducing costimulatory signals,
thus ‘‘tricking’’ the adaptive immune system into action. These
and other ideas provided an elegant explanation of many funda-
mental aspects of the functioning of the immune system.
Remarkably, all of them turned out to be fundamentally correct.
Nevertheless, the new theory did not seem to attract a lot of
attention at first. The situation started to change about a decade
later, when new studies began elucidating the pathways of
innate immune recognition.
Toll-like Receptors
By the mid-90s, several receptors involved in innate immune
recognition were already known. These included CD14, a compo-
nent of the LPS receptor complex (Wright et al., 1990); Mannan-
binding lectin (MBL), an activator of the lectin pathway of comple-
ment (Takahashi et al., 2006); macrophage mannose receptor
(Stahl and Ezekowitz, 1998); and MARCO, a member of the scav-
enger receptor family (Elomaa et al., 1995). MBL was particularly
well characterized in terms of its specificity and function. Its role
in complement activation and microbial opsonization was remi-
niscent of immunoglobulins, suggesting that MBL functioned as
a nonclonal version of antibodies. To emphasize this point, Alan
Ezekowitz referred to MBL as ‘‘ante-antibody,’’ highlighting the
evolutionary ancestry of the former (Ezekowitz, 1991). However
MBL, as well as pentraxins, although known at the time to func-
tion as pattern recognition molecules, were not the type of recep-
tors that would be expected to control the expression of costimu-
latory signals on APCs. Therefore, Janeway and his colleagues
were looking for cell-surface receptors, expressed on macro-
phages and dendritic cells (DCs), that would be able to induce
signaling pathways resulting in expression of B7.1 and B7.2
(now known as CD80 and CD86, respectively). Because many
PAMPs are either carbohydrates or glycolipids, the new pattern
recognition receptors were thought to probably contain a C-
type lectin domain, similar to MBL and macrophage mannose
receptor. In addition, the intracellular portion was expected to
be linked to the activation of the NF-kB signaling pathway. This
pathway was already well established to play a pivotal role in
innate immunity (Kopp and Ghosh, 1995), and studies by Stepha-
nie Vogel, Doug Golenbock, Richard Ulevitch, and many others
have demonstrated the role of NF-kB in LPS signaling. The
best-characterized receptors known at the time to activate NF-
kB were TNF and IL-1 receptors. The IL-1 receptor was particu-
larly interesting in this regard because it contained a cytoplasmic
domain, which was known to occur inDrosophilaToll, identified in
1988 by Carl Hashimoto and Kathryn Anderson (Hashimoto et al.,
1988), and in a resistance protein from tobacco known as N
protein, which gave it the name TIR (for Toll, IL-1R, and Resis-
tance protein) domain (Gay and Keith, 1991; Whitham et al.,
1994). The idea therefore was to find a new transmembrane
protein that would contain a C-type lectin ectodomain and a cyto-
plasmic TIR domain.
In early 1996, a piece of an expressed sequence tag sequence
was identified in the NCBI database as containing similarity to
a portion of a TIR domain and used to screen a splenic cDNAImmunity 30, June 19, 2009 ª2009 Elsevier Inc. 767
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contain a C-type lectin domain. Instead, it was a homolog of
Drosophila Toll, which was known to have an endogenous
protein ligand Spatzle (Schneider et al., 1994). Moreover, one
sequence with similarity to Drosophila Toll was deposited in
the database as ‘‘randomly sequenced cDNA 786’’ (rsc786)
(Nomura et al., 1994), and it was reported in early 1996 that the
protein it encoded did not activate NF-kB (Mitcham et al.,
1996). The reason for this negative result was that rsc786 is
what is now known as TLR1, which was subsequently shown
by Alan Aderem and colleagues to signal only as a heterodimer
with TLR2. However, the clone isolated in the Janeway lab en-
coded what is now known as TLR4, which functions as a homo-
dimer, and accordingly, its constitutively active form was able to
induce NF-kB. Furthermore, a few months later, in the summer of
1996, we learned from Jules Hoffmann about their stunning
discovery of the essential role of Drosophila Toll in antifungal
defense. This finding (Lemaitre et al., 1996) further reinforced
the possibility that a mammalian Toll homolog may also have
an immune function, and indeed it turned out to induce expres-
sion of genes encoding B7 and several cytokines (Medzhitov
et al., 1997), suggesting that TLR may couple innate immune
recognition with activation of adaptive immunity (Fearon,
1997). On the basis of this, and given the immune function of
Drosophila Toll discovered by Bruno Lemaitre and Jules Hoff-
mann, human Toll was suggested to be involved in recognition
of microbial PAMPs (Medzhitov and Janeway, 1997). The
assumption at the time was that similar to its fly counterpart it
would function downstream of a proteolytic cascade triggered
by microbial recognition. However, the identity of the TLR
ligands remained unknown for another year, despite numerous
attempts by multiple groups to test whether human TLR4 was
a receptor for LPS. All these attempts failed because the other
key component of the LPS receptor complex, MD2, was not
known at the time and was discovered by Kensuke Miyake and
colleagues only two years later (Shimazu et al., 1999). In the
meantime, several additional members of the Toll-like receptor
family were identified (Chaudhary et al., 1998; Rock et al., 1998).
The first evidence that TLRs may indeed be involved in micro-
bial recognition was provided by Paul Godowsky and colleagues
(Yang et al., 1998). This study indicated that TLRs could directly
respond to bacterial products. Specifically, it reported that TLR2
conferred responsiveness to crude preparations of LPS, which
also contained bacterial lipoproteins. The same result was also
reported a few months later by a group from Tularik (Kirschning
et al., 1998). We now know that TLR2 in these experiments
responded to lipoproteins rather than to LPS (Hirschfeld et al.,
2000). Nevertheless, the demonstration that a TLR recognized
a microbial stimulator had its impact because it immediately sug-
gested that all mammalian TLRs may recognize different micro-
bial ligands and that unlike Drosophila Toll, they may recognize
them directly. In a commentary piece accompanying Godow-
sky’s paper, Craig Gerard pointed out that the gene encoding
human TLR4 was located in a chromosomal region (9q32-33)
syntenic to mouse chromosome 4, in which LPS unresponsive-
ness in the C3H/HeJ strain was previously mapped, suggesting
that TLR4 may be involved in LPS recognition (Gerard, 1998).
Positional cloning of the lps locus by Bruce Beutler and
colleagues (Poltorak et al., 1998) demonstrated that TLR4 was768 Immunity 30, June 19, 2009 ª2009 Elsevier Inc.required for LPS responsiveness, thus providing the first genetic
evidence for TLR4 function in microbial recognition. The same
result was later reported by Danielle Malo and colleagues (Qure-
shi et al., 1999). Subsequent studies by Shizuo Akira and many
others have elucidated the specificities of other TLRs for various
microbial ligands (Takeda et al., 2003). Thanks to these contribu-
tions, we now know that TLRs detect a variety of bacterial, viral,
fungal, and protozoal ligands. TLR signaling pathways have also
been elucidated in some detail, again in large part because of the
numerous gene ‘‘knockout’’ mice generated by Shizuo Akira and
colleagues. The latest breakthrough in the TLR field was the
elucidation of the structures of several TLRs, in some cases in
complex with their ligands (Jin and Lee, 2008). These structures
allowed us to see in great detail the structural principles of
pattern recognition.
Other Pattern Recognition Receptors
and Their Functions
Elucidation of the functions of TLRs in mammalian immunity has
provided experimental support for the concept proposed by
Charlie Janeway two decades ago. However, TLRs are not the
only sensors of microbial infection. In May of 1999, two indepen-
dent studies reported identification and initial characterization of
NOD1, a founding member of a family of cytosolic receptors
(Bertin et al., 1999; Inohara et al., 1999). NOD1 and a related
protein, NOD2, were subsequently found to sense fragments
of bacterial peptidoglycans (Chamaillard et al., 2003; Girardin
et al., 2003a; Girardin et al., 2003b; Inohara et al., 2003). The
role of NOD proteins in host defense is still being elucidated,
but genetic studies have revealed their role in intestinal immunity
(Kobayashi et al., 2005), inflammation (Maeda et al., 2005), and
the pathogenesis of Crohn’s disease (Hugot et al., 2001; Ogura
et al., 2001). In 2001, Gordon Brown and Siamon Gordon identi-
fied Dectin-1 as a receptor for b-glucans (Brown and Gordon,
2001). In subsequent studies, Dectin-1 was found to play impor-
tant roles in antifungal immunity (Gross et al., 2006; Leibundgut-
Landmann et al., 2007; Saijo et al., 2007; Taylor et al., 2007). In
2004, Takashi Fujita and colleagues identified RIG-I and MDA-5
as intracellular sensors for double-stranded RNA (Yoneyama
et al., 2004). RIG-I was also found in a screen for mutations
permissive for hepatitis C virus replication (Sumpter et al.,
2005). RIG-I and MDA-5 were later shown to play essential roles
in sensing RNA viruses and initiating antiviral immunity (Gitlin
et al., 2006; Kato et al., 2005; Kato et al., 2006). Definition of
the RNA ligands recognized by RIG-I revealed the molecular
pattern sensed by this receptor (Hornung et al., 2006; Pichlmair
et al., 2006). Finally, in 2002, Ju¨rg Tschopp and colleagues
described the inflammasomes-multiprotein complexes that acti-
vate caspase-1 and other inflammatory caspases to generate
and secrete mature forms of IL-1 family members (Martinon
et al., 2002). Although it is not yet clear how all the different in-
flammasomes are activated, at least some of them may function
as components of a pattern recognition system (Meylan et al.,
2006).
Together with pentraxins, collectins, and ficolins (Bottazzi
et al., 2006; Holmskov et al., 2003), these newly identified pattern
recognition receptors account for most of the pathogen-sensing
capabilities of mammalian hosts (Figure 1). However, there are
clearly additional pathogen recognition systems that remain to
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in recognition of viral and bacterial DNA that trigger the type I
interferon response (Ishii et al., 2006; Okabe et al., 2005; Stetson
and Medzhitov, 2006). It is likely that there is more than one
receptor involved in intracellular sensing of microbial DNA
(Takaoka et al., 2007). Another example is the receptor(s)
involved in the recognition of chitin. Chitin is an abundant poly-
saccharide produced by arthropods and parasitic worms, and
it was recently demonstrated that chitin can trigger a type 2
inflammatory response (Reese et al., 2007). At least some of
the activities of chitin are mediated by TLR2 (Da Silva et al.,
2008), although additional receptors are likely to exist. Other
receptors involved in recognition of parasitic worms remain to
be identified. Innate immune recognition of helminthes is poorly
understood, and it is not even clear to what extent pattern recog-
nition plays a role here. Indeed, multicellular parasites may not
be evolutionarily distant enough from mammalian hosts to
produce reliable targets for pattern recognition receptors. With
the exception of chitin, there are no other known molecular pro-
ducts that are conserved among parasites and distinct from the
mammalian hosts. Therefore, pattern recognition may not play
a major role in the detection of multicellular parasites. Instead,
other forms of innate immune recognition may play a predomi-
nant role (see below).
Pattern recognition also does not explain immune responses
to transplants and to most allergens. However, there is no other
theory (and there may never be) that can explain all immune
responses, simply because they do not all follow the same rules.
Figure 1. Pattern Recognition Receptors
Major classes of mammalian pattern recognition
receptors and some of their representative micro-
bial ligands are shown. Secreted pattern recogni-
tion molecules activate complement and function
as opsonins. Transmembrane and intracellular
receptors trigger signaling pathways for innate
host defense and activate adaptive immune re-
sponses. Mechanisms of inflammasome activa-
tion are still being defined. NLRs, NOD-like recep-
tors; CRD, carbohydrate recognition domain;
ITAM, immunoreceptor tyrosine-based activation
motif.
Rather, different mechanisms of immune
recognition may sometimes work in
specific combinations to trigger optimal
immune responses. Therefore, different
theories need not be competing, so long
as they explain distinct phenomena.
Thus, in addition to pattern recognition
theory, three other concepts have been
proposed to explain the mechanisms of
activation of immune responses. These
are the missing self theory, the guard
theory, and the danger theory.
Missing Self Recognition
The missing self concept was proposed
by Klas Ka¨rre to explain the specificity
of tumor cell recognition by NK cells
(Karre et al., 1986). The molecular basis
for missing self recognition by NK cells is the engagement of
a class of inhibitory receptors (initially discovered by Wayne Yo-
koyama and colleagues), typically containing immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) (Karlhofer et al., 1992).
They recruit SHP-1 tyrosine phosphatase to block Syk-72
dependent NK activating pathways, including cytotoxicity (Rau-
let and Vance, 2006). The missing self concept also applies to
many other forms of innate immune recognition. Activation of
the alternative complement pathway (Gotze and Muller-Eber-
hard, 1971), for example, is negatively regulated, among other
things, by Factor H, which can distinguish between microbial
and host cells by binding to host-specific sialic acids and pre-
venting the alternative pathway of complement activation on
host cells (Meri and Pangburn, 1990). There is growing evidence
that phagocytosis is also negatively regulated by a variety of
ITIMs containing inhibitory receptors, including SIRPa and prob-
ably Siglec proteins. Thus, recognition of CD47 on target cells by
SIRPa prevents their phagocytosis by macrophages (Oldenborg
et al., 2000). Siglecs may play a similar role by recognizing host-
specific sialic acids, analogously to Factor H (Crocker and Varki,
2001). Sialic acid recognition on antigens by CD22 may play
a similar role in controlling B cell activation (Doody et al., 1995).
It should be noted that missing self recognition is essentially
a negative control of some activating signal and thus always
works in conjunction with an activating pathway. The activating
signal itself can be triggered by a variety of mechanisms. Thus,
the alternative complement pathway is activated by properdin,
which was discovered in the early 1950s by Louis PillemerImmunity 30, June 19, 2009 ª2009 Elsevier Inc. 769
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recognition protein (Kemper and Hourcade, 2008). Phagocytosis
is positively regulated by a variety of phagocytic receptors
(Underhill and Ozinsky, 2002), some of which are pattern recog-
nition receptors that directly recognize microbial cells. Finally,
NK cell cytotoxic activity is triggered by activating receptors,
which recognize ligands that are induced on target cells upon
viral infection and by some forms of stress (Lanier, 2005). How
these ligands are induced in virally infected cells is not yet well
defined, but it is possible that the intracellular sensors of viral
infections, such as RIG-I and MDA-5, may play a role. Thus it
appears that in some (but certainly not all) cases, the positive
signals that are opposed by the ‘‘missing self’’ pathways may
be inducible by the pattern recognition receptors. In other cases,
they may be triggered by mechanisms that are explained by the
guard theory.
Guard Theory
Another theory of immune recognition, known as ‘‘guard theory,’’
was proposed by Dangl and Jones to explain the genetics of host
resistance in plants (Dangl and Jones, 2001). Individual resis-
tance genes in plants are often required to confer protection
from a specific strain of pathogen carrying a particular virulence
factor. (In keeping with the overly confusing terminology in
animal immunity, ‘‘virulence factors’’ in plant immunity are re-
ferred to as ‘‘avirulence factors.’’) The idea of the guard theory
is that rather than detecting pathogens directly, the products
of at least some individual resistance genes monitor, or ‘‘guard,’’
certain cellular processes that are often targeted by the virulence
factors of pathogens. Disturbances in these processes are
sensed by resistance gene products, which become activated
and trigger a host defense response, for example, the hypersen-
sitivity response. This form of microbial detection thus does not
require direct molecular recognition of the pathogen, but rather is
based on sensing the results of virulence factor activity by moni-
toring their effects on the host. Because plants also use pattern
recognition for pathogen sensing, it is likely that the two mecha-
nisms normally work together (Jones and Dangl, 2006).
Do the principles of guard theory apply to animal immunity?
Two lines of recent evidence suggest that they do. First, at least
some inflammasomes (specifically the NALP3 inflammasome)
appear to function by monitoring cellular membrane integrity
(Ogura et al., 2006). As it happens, cellular membrane integrity
is often targeted by pathogens. Many Gram-positive pathogens,
for example, produce pore-forming exotoxins that can be se-
nsed by the NALP3 inflammasome (Mariathasan et al., 2006).
The NALP3 inflammasome can also be activated by noninfec-
tious stimuli that affect cellular membranes, although the mech-
anisms involved remain poorly defined (Martinon et al., 2009).
Interestingly, NALP3 and other NOD-like receptors are structur-
ally similar to the products of many plant resistance genes,
although it is too early to say whether this similarity extends to
their mechanisms of action.
The second example of sensing virulence activity is based on
the detection of a proteolytic activity. In Drosophila, the proteo-
lytic cascade that leads to processing of Spatzle and activation
of Toll is normally triggered by pattern recognition molecules
(Hoffmann, 2003), but can also be triggered by a virulence factor
(a protease) secreted by a fungal pathogen. This protease, in turn,770 Immunity 30, June 19, 2009 ª2009 Elsevier Inc.can trigger (and therefore is sensed by) the Spatzle-activating
proteolytic cascade resulting in the induction of antifungal immu-
nity (Gottar et al., 2006). In mammals, proteolytic activity of
protease allergens is detected by unknown sensors expressed
on basophils, resulting in the initiation of a T helper 2 cell response
(Sokol et al., 2007). This mechanism of allergen sensing presum-
ably evolved to detect proteases secreted by parasitic worms,
whereas allergens happen to trigger the same pathway inadver-
tently. As mentioned above, the pattern recognition strategy may
not be sufficient or even practical for the detection of multicellular
parasites. The host may have evolved instead a set of sensors
that detect abnormal biochemical activities associated with
helminth infections, much like guard proteins in plants detect
activities of virulence factors. Cell-autonomous sensing of
cellular perturbations associated with viral infections may also
be coupled with the induction of positive signals for NK cell acti-
vation.
Interestingly, in some contexts, inflammasome activation and
IL-1 production are critical for the induction of T cell responses
(Ben-Sasson et al., 2009; Ichinohe et al., 2009), just as sensing
of allergen protease activity by basophils is critical for Th2 cell
responses (Sokol et al., 2007). This suggests that indirect
sensing of ‘‘virulence activity’’ can indeed be linked with the acti-
vation of adaptive immunity.
Danger Theory
The danger theory was proposed by Polly Matzinger in 1994 as
an alternative to self-nonself discrimination theories (Matzinger,
1994). The main point of the danger model is that the immune
system is not concerned with the origin of the antigen. Rather,
the immune response was suggested to be initiated by ‘‘danger
signals’’ released from damaged tissues. Thus, anything that can
cause tissue damage, be it a pathogen or a surgical procedure,
was proposed to induce an immune response. Benign stimuli not
associated with tissue damage, whether microbial or not, were
proposed to be ignored by the immune system. Thus, according
to the danger model, initiation of the immune response is not
dependent on microbial recognition, but rather on the ability of
pathogens (or a transplantation procedure) to cause tissue
damage. Moreover, according to the danger model, pattern
recognition receptors (for example, TLRs) did not evolve to
recognize their microbial ligands (for example, LPS); rather, the
microbial ligands evolved to bind to and activate TLRs (Mat-
zinger, 2002).
Although the danger theory gained popularity in the past
decade, there appears to be a lot of confusion as to what exactly
is considered to be ‘‘danger signals.’’ The term ‘‘danger signal’’ is
now often used to refer to microbial TLR ligands, which is ironic
because the implication is the exact opposite of the main postu-
late of the danger theory. In other cases, PAMPs are being distin-
guished from DAMPs (damage-associated molecular patterns).
There are certainly signals released from damaged tissues that
trigger inflammatory and tissue repair responses. Tissue damage
of course initiates the inflammatory response, but in the absence
of infection, this response leads to tissue repair, rather than adap-
tive immunity, which in this case should be autoreactive. It is clear
that microbial ligands of pattern recognition receptors can trigger
the immune response even in isolation from the pathogens. Simi-
larly, nonpathogenic microbes that do not cause tissue damage
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by the generation of IgA antibodies specific to commensal
bacteria (Macpherson and Slack, 2007). Thus, microbial recogni-
tion appears to be sufficient to initiate the immune response, even
in the absence of tissue damage.
Microbial recognition, however, does not explain all adaptive
immune responses. Some types of cell death are thought to be
immunogenic in some contexts (Green et al., 2009; Rock and
Kono, 2008), and receptors that can sense immunogenic forms
of cell death are beginning to be identified (Sancho et al., 2009;
Yamasaki et al., 2008). Certain aspects of the danger model
may indeed be valid; tissue damage is likely to play a role in the
regulation of immune responses, although it is unlikely to be
necessary or sufficient to induce an adaptive immune response.
But then again, this depends on the definition of adaptive immune
responses. If there are adaptive immune responses that play
roles other than protection from microbial infections, than we
will all have to reconsider many of the arguments on which we
currently rely.
The Janeway model and the Matzinger model started off as
alternative views on the mechanisms of initiation of immunity.
The two models have now coexisted for 15 years. As Francis
Crick once noted: ‘‘The basic trouble is that nature is so complex
that many quite different theories can go some way to explaining
the results.’’ Eventually, the differences in our views will un-
doubtedly degenerate into purely semantic arguments, at which
point they will become irrelevant.
Innate Control of Adaptive Immunity
The principles of innate control of adaptive immunity have been
discussed before (Fearon and Locksley, 1996; Iwasaki and
Medzhitov, 2004) and will not be covered here in detail. However,
some aspects of this important subject have recently become
controversial, thus generating a great deal of confusion.
As discussed above, several families of pattern recognition
receptors are now known and a few more remain to be identified.
In addition, other strategies of innate immune recognition, in
particular sensing of virulence activities and missing self recog-
nition, are likely to play an important role in the control of adap-
tive immunity. It is now well established that several pattern
recognition receptors are coupled with the induction of adaptive
immunity, including TLRs, NLRs, Dectin-1, RIG-I, and MDA-5
(Palm and Medzhitov, 2009b). Additional, currently unknown
receptors that can induce adaptive immune responses must
exist as well because some immune responses (for example,
some Th2 cell responses) cannot be accounted for by any of
the known innate immune-sensing mechanisms. It should also
be self-evident that if more than one pathway is sufficient to
induce an immune response, then none of the individual path-
ways is required in general, except in the absence of stimuli for
any of the alternative pathways. Numerous studies have now
demonstrated that some adaptive immune responses are
dependent on the TLR-MyD88 pathway, whereas others are
not (Palm and Medzhitov, 2009b). However, a recent report
(Gavin et al., 2006) claimed that TLRs are not involved in the
control of adaptive immunity and that common adjuvants do
not work through TLRs. This caused a great deal of confusion,
given that the reasons for these discrepant results were unclear.
That main reason for the discrepancy, as it turns out, has to dowith the type of antigen used in immunizations. Unlike the
previous publications (Pasare and Medzhitov, 2004, 2005), in
which native protein antigens were used for immunizations,
Gavin et al. exclusively examined immune responses to hapten-
ated antigens. However, haptenated antigens, unlike native
protein antigens, have intrinsic immunogenic activity (Palm and
Medzhitov, 2009a). Thus, the results reported by Gavin et al.
are not directly comparable to the previous reports. Second,
adjuvants have at least two types of activities: First, they trigger
innate immune recognition pathways, commonly by engaging
one or more pattern recognition receptors, and second, mineral
oil (a component of Freund’s adjuvants) and alum have a depot
effect that is critical when soluble antigens are used (but prob-
ably dispensable for particulate antigens). Thus the TLR-inde-
pendent, adjuvant-mediated enhancement of the antibody re-
sponse to haptenated antigens reported by Gavin et al. most
likely reflects the depot effect, as previously reported for
MyD88-independent Th2 cell responses (Schnare et al., 2001).
Immunogenicity, on the other hand, was provided as a result of
the use of haptenated antigens. The fact that TLRs are not
required for all immune responses have been well documented
before (Rivera et al., 2006; Schnare et al., 2001; Way et al.,
2003), as is the fact that TLRs and several other pattern recogni-
tion receptors are sufficient to induce adaptive immunity,
thereby making the requirement for any particular receptor
dependent on the pathogen or antigen and adjuvant used in
immunization.
TLRs in Human Immunity
Recent studies have uncovered an important role of TLRs in
human immunity. Thus, individuals carrying mutations in TLR5
were found to be susceptible to Legionnaires’ disease (Hawn
et al., 2003). Surprisingly, TLR3 deficiency in humans resulted
in susceptibility to herpes simplex encephalitis (Zhang et al.,
2007). In addition, patients with null mutations in IRAK4 and
MyD88 are highly susceptible to several bacterial infections,
which often result in lethality early in life (Ku et al., 2007; Medve-
dev et al., 2003; von Bernuth et al., 2008). If the patients passed
the critical period in the first few years of life, however, compen-
satory host defense mechanisms, presumably in large part
antibody-mediated, afford protection from some pathogens,
although the patients still suffer from recurrent pyogenic bacte-
rial infections. Although these findings were interpreted as indi-
cating a narrowly restricted and redundant role of TLRs in human
immunity (Ku et al., 2007), this interpretation is incongruent with
the fact that almost half of the patients with IRAK4 deficiency die
from infections, even though a majority of the patients are pre-
sumably on antibiotic medications. In a ‘‘natural’’ environment,
without modern medical interference, presumably all of them
would be dead from infections early in life. Clearly, however, in
some of the patients examined so far, the adaptive immune
response can partially compensate for TLR signaling defects. It
would be interesting to learn in the future the rules of immunolog-
ical compensation, which presumably operate in most types of
nonlethal immunodeficiencies.
Conclusions
The 20 years that passed since Janeway’s publication have seen
a tremendous progress in our understanding of the innateImmunity 30, June 19, 2009 ª2009 Elsevier Inc. 771
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Perspectiveimmune system and its role in mammalian host defense. Still, to
be sure, we will continue ‘‘approaching the asymptote’’ for many
more years. No theory is ever complete, and pattern recognition
concept will continue to evolve and eventually integrate with
other concepts into a more general theory. We soon will know
the entire repertoire of pattern recognition receptors and will
learn more about other innate immune-sensing mechanisms.
We will then be able to learn all possible pathways for the activa-
tion of adaptive immunity. Perhaps at that point we will be able to
address far more daunting questions of the requirements for the
generation of protective immunity. Here we know very little, and
this in part explains our continuous failures in developing new
effective vaccines. Once the principles of protective immunity
are understood, we may finally be able to deliver on the promise
of defeating major infectious diseases with vaccination. But then
again, pathogens may have a different opinion on this matter.
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